Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017160 (
gastroenteritis
)
11,398
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rotavirus is an important cause of acute
gastroenteritis
in many species of animals and humans, and is responsible for about 870,000 deaths annually among children under 5 years old, mostly in developing countries.
Rotavirus disease
will most likely be controlled through the development and widespread use of an effective vaccine. In anticipation of the possible use of such a vaccine in Brazil, the authors characterized the most common strains of rotavirus in circulation in the country. Reverse transcription-polymerase chain reaction (RT-PCR) was used to determine the P and G genotypes of 130 culture-adapted rotavirus strains isolated from 181 fecal specimens of children under age 5 years from 9 states and the Federal District of Brazil. The 4 genotypes found most commonly worldwide were also common in Brazil, with P[8]G1 being the most prevalent in 43% of cases, followed by P[4]G2 (12%), P[8]G3 (6%), and P[8]G4 (6%). The unusual types P[8]G5, P[6]G2, P[9]G1, and P[9]G3 were responsible for 12% of the cases, and mixed infections were responsible for 21% of cases. Genotype G5 strains were detected in specimens collected in all 9 areas surveyed from all 4 regions of Brazil. This unusual strain diversity in Brazil suggests that when tetravalent rotavirus vaccines currently being developed are introduced into Brazil, laboratory surveillance will be key to monitoring protection against unusual strains, especially those of genotype 5, as well as new reassortants which may evolve from the pool of children with mixed infections.
...
PMID:Rotavirus G and P types circulating in Brazil: characterization by RT-PCR, probe hybridization, and sequence analysis. 952 43
We examined the epidemiological profile of rotavirus infection among children hospitalized for diarrhea in Taiwan, to assess the burden of this disease. From 1 April 2001 through 31 March 2003, children <5 years old with
gastroenteritis
admitted to 4 sentinel hospitals were enrolled in a surveillance study and had stool specimens tested for the presence of rotavirus, enteric adenovirus, and the bacterial pathogens for which routine screening is performed. For 52% of patients, a recognized enteric pathogen was identified, including rotavirus (43% of patients), bacteria (11%), enteric adenovirus (2.5%), and a mixture of pathogens (3.9%). Rotavirus was detected year-round, but great month-to-month variability made it difficult to identify a distinct seasonal pattern.
Rotavirus disease
was most common among children 7-23 months old, but the rate of rotavirus detection varied little between the youngest and oldest age groups. The novel strain P[8]G9 was detected most commonly (37% of strains), followed by strains P[8]G1 (31%), P[4]G2 (10%), P[8]G3 (9.3%), and P[8]G4 (3.7%). Rotavirus infection is the most important cause of diarrhea among hospitalized children in Taiwan, and a rotavirus vaccination program for young children might significantly reduce this problem.
...
PMID:Sentinel hospital surveillance for rotavirus diarrhea in Taiwan, 2001-2003. 1608 4
Two new rotavirus vaccines are expected to be introduced in the European Union (EU) in coming years. A human rotavirus vaccine has already been licensed in several countries worldwide, and a pentavalent bovine vaccine has been submitted for licensure in the United States and the EU. Few data exist on the burden of rotavirus disease and its associated costs within the EU. To estimate the burden of rotavirus disease in the EU, we adapted a model based on the approach developed by the Centers for Disease Control and Prevention to the European situation and applied it to recent population and mortality data from European countries. Country-specific estimates were added to obtain a global estimate of rotavirus episodes treated at home, clinic visits, hospitalization and death. We estimate that 3.6 million episodes of rotavirus disease occur annually among the 23.6 million children younger than 5 years of age in the EU. Every year, rotavirus accounts for 231 deaths, >87,000 hospitalizations and almost 700,000 outpatient visits.
Rotavirus disease
constitutes a large public health burden in the EU. Except for deaths, the burden of disease is not dissimilar to that in the developing world. Country-specific studies are required to more accurately understand the burden of disease caused by rotavirus. With the introduction of new rotavirus vaccines in sight, rotavirus
gastroenteritis
may be regarded as the single most frequent vaccine-preventable disease among children in the EU.
...
PMID:Burden of rotavirus disease in European Union countries. 1639 31
Rotavirus infection is the most common cause of severe diarrhea disease in infants and young children worldwide and continues to have a major global impact on childhood morbidity and mortality. Vaccination is the only control measure likely to have a significant impact on the incidence of severe dehydrating rotavirus disease.
Rotavirus disease
prevention efforts suffered a severe setback in 1999 with the withdrawal of the RRV-TV vaccine less than a year after its introduction. Several new rotavirus vaccines have been developed and have proven to be safe and efficacious. These new safe and effective rotavirus vaccines offer the best hope of reducing the toll of acute rotavirus
gastroenteritis
in both developed and developing countries.
...
PMID:Rotavirus vaccines--an update. 1732 Oct 17